EARLY HBEAG LOSS DURING PEGINTERFERON ALPHA-2B THERAPY PREDICTS HBSAG LOSS - RESULTS OF A LONG-TERM FOLLOW-UP STUDY IN CHRONIC HEPATITIS B | AVESİS

Hacettepe University Research Information System

EARLY HBEAG LOSS DURING PEGINTERFERON ALPHA-2B THERAPY PREDICTS HBSAG LOSS - RESULTS OF A LONG-TERM FOLLOW-UP STUDY IN CHRONIC HEPATITIS B

Copy For Citation

Buster E. H., Flink H. J., ŞİMŞEK H., Heathcote E. J., Sharmila S., Kitiss G. E., ...More

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48

Publication Type: Conference Paper / Summary Text
Volume: 48
City: San-Francisco
Country: Costa Rica
Hacettepe University Affiliated: Yes